Interesting facts
Interesting Facts about 7-Fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
This compound is a fascinating member of the larger family of synthetic organic chemicals, specifically classified as a complex polycyclic compound. Here are some intriguing aspects of this compound:
- Pharmaceutical Potential: Due to its unique structure, this compound has been studied for potential applications in pharmaceuticals, particularly in the treatment of various disorders. Its specific substitutions may enable interactions with biological targets.
- Fluorine's Role: The presence of fluorine, specifically in the 7-fluoro position, is linked to improved metabolic stability and altered lipophilicity, making it a valuable modification in medicinal chemistry.
- Molecular Complexity: The intricate tricyclic structure poses challenges in synthesis and characterization, which is typical for drug development. The unique arrangement of carbon and nitrogen atoms contributes to its intriguing chemical behavior.
- Mechanism of Action: While still under investigation, compounds of this type may exert their effects through unique interactions with receptors or enzymes, leading to valuable therapeutic outcomes.
- Research Status: This compound is likely on the frontier of compound libraries being screened for bioactivity, highlighting the importance of structure-activity relationship (SAR) studies in drug discovery.
Scientists are continually fascinated by compounds with such complexity, as they often represent the intersection of synthetic organic chemistry and pharmacology. As research progresses, we may discover even more exciting applications for this compound in various fields.
Synonyms
ofloxacin
82419-36-1
Floxin
Ofloxacine
Tarivid
Ocuflox
Oxaldin
Ofloxacino
Oflocet
Visiren
Ofloxacinum
DL-8280
Hoe-280
OFLX
Ofloxacina
Exocin
Floxin otic
Ofloxacin Otic
HOE 280
Ofloxacinum [Latin]
FLOXIN IN DEXTROSE 5%
83380-47-6
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
MFCD00226105
ORF 18489
CCRIS 5233
CHEBI:7731
UNII-A4P49JAZ9H
A4P49JAZ9H
NSC-727071
NSC-758178
Exocin (eye drops)
BRN 3657947
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
DTXSID3041085
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
HSDB 8030
CHEMBL4
J01MA01
Dextrofloxacin
MLS000028749
7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
DTXCID1021085
NSC727071
Ofloxacinum (Latin)
NSC 727071
NSC 758178
Ofloxacin [USAN:USP:INN:BAN:JAN]
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
OFX
Ofloxacina [DCIT]
Ofloxacine [French]
Exocine
Flobacin
Ofloxacin 100 microg/mL in Acetonitrile
SMR000058192
Zanocin
Floxil
Ofloxacino [Spanish]
OFLOXACIN (MART.)
OFLOXACIN [MART.]
OFLOXACIN (USP-RS)
OFLOXACIN [USP-RS]
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-
OFLOXACIN (EP MONOGRAPH)
OFLOXACIN [EP MONOGRAPH]
OFLOXACIN (USP MONOGRAPH)
OFLOXACIN [USP MONOGRAPH]
DL 8280
MFCD00865049
PT 01
Ofloxacin (USAN:USP:INN:BAN:JAN)
7-Fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13),11-tetraene-11-carboxylic acid
9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-7H-PYRIDO(1,2,3-DE)(1,4)BENZOXAZINE-6-CARBOXYLIC ACID, DL-
Floxin (TN)
(+/-)-Floxin
SR-01000076050
Hoe280
Monoflocet
Ofloxaxin
DL-ofloxacin
Ofloxacin,(S)
NCGC00016948-01
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-(1,4)oxazino(2,3,4-ij)quinoline-6-carboxylic acid
Ofloxacin (Floxin)
Ofloxacin Ophthalmic
Olfoxacin Otic Soln
CAS-82419-36-1
DL8280
Ofloxacin Ophth Soln
Ofloxacin (Standard)
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
WP-0405
Levofloxacin-13C-D3
Spectrum_001186
OFLOXACIN [INN]
OFLOXACIN [JAN]
OFLOXACIN [MI]
OFLOXACIN [USAN]
Opera_ID_1114
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
OFLOXACIN [VANDF]
Epitope ID:116889
O 8757
OFLOXACIN [WHO-DD]
Lopac0_000904
Oprea1_242882
SCHEMBL24373
BSPBio_000313
BSPBio_003117
KBioGR_000667
KBioSS_001666
fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid
MLS001074203
MLS006011774
DivK1c_000721
SPECTRUM1502044
SPBio_001387
SPBio_002234
(S)-Ofloxacin;Levaquin;Quixin
Ofloxacin (JP18/USP/INN)
BPBio1_000345
OFLOXACIN [ORANGE BOOK]
SCHEMBL14163982
GTPL10918
HMS502E03
HY-B0125R
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
S01AE01
S02AA16
CHEBI:194135
NINDS_000721
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS2095P15
HMS2235C05
HMS3259G07
HMS3262F10
HMS3369B01
HMS3393K06
HMS3604B17
HMS3712P15
Pharmakon1600-01502044
(3R)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
BCP14346
BCP22048
HY-B0125
RKL10083
UYB17021
Ofloxacin, fluoroquinolone antibiotic
Tox21_110703
Tox21_500904
BBL005605
BDBM50045004
CCG-39210
NSC758178
s1463
STK256723
AKOS001033517
AKOS016042783
Ofloxacine; DL-8280; HOE-280
Tox21_110703_1
1ST5740
AC-7616
AO26535
BCP9000851
CS-1891
DB01165
KS-5011
LP00904
NC00466
SDCCGSBI-0050879.P004
IDI1_000721
NCGC00015772-02
NCGC00015772-03
NCGC00015772-04
NCGC00015772-05
NCGC00015772-06
NCGC00015772-07
NCGC00015772-08
NCGC00015772-09
NCGC00015772-10
NCGC00015772-12
NCGC00015772-13
NCGC00015772-22
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NCGC00261589-01
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
9-Fluoro-3,7-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid
SY007392
SY052697
SBI-0050879.P003
DB-056608
AB00513820
EU-0100904
NS00098749
O0403
EN300-06482
Ofloxacin, VETRANAL(TM), analytical standard
VU0243192-7
C07321
D00453
AB00052263-12
AB00052263-13
AB00052263_14
AB00052263_15
Q411447
SR-01000076050-1
SR-01000076050-4
SR-01000076050-7
BRD-A24228527-001-05-9
BRD-A24228527-001-19-0
BRD-A24228527-001-31-5
BRD-A24228527-213-01-9
SR-01000076050-16
Z56761309
F0020-0095
F0472-0226
138199-71-0 (0.5H2O)
Ofloxacin, European Pharmacopoeia (EP) Reference Standard
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
(+/-)-9-Fluoro-2,2,3-de)-1,4-benzoxazine-6-carboxylic acid
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
(+/-)-9-Fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7--oxo-7H-pyrido(1,2,3-de)--1,4-benzoxazine-6-carboxylic acid
(3RS)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid
7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0,5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
7H-PYRIDO(1,2,3-DE)-1,4-BENZOXAZINE-6-CARBOXYLIC ACID, 9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-, (+/-)-
9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid;Ofloxacine;DL- 8280
9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de]-1,4-Benzoxazin-6-carboxylic Acid
9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylicacid
9-fluoro-3-methyl-10-(4-methylpiperazino)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
Solubility of 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
The solubility of organic compounds such as 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid (C21H24FN3O4) can greatly influence their practical applications and bioavailability.
Here are some key considerations regarding its solubility:
In conclusion, the solubility of this complex compound will be contingent upon the interplay of these factors. Understanding these variables is crucial for predicting how the substance will behave in different environments, particularly in pharmaceutical applications where solubility is key to efficacy and absorption.